ArticleInternal medicine (Tokyo, Japan)2024
De novo Hepatitis B Virus Reactivation during Treatment with an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Patient with Advanced Lung Cancer.
Ryota Horibe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.